Pulmonary mucormycosis in systemic lupus erythematosus: successful management of a case along with review of literature.

Szczegóły
Abstrakt

Tytuł:: Pulmonary mucormycosis in systemic lupus erythematosus: successful management of a case along with review of literature.
Autorzy:: Kharbanda R; Departments of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Mehndiratta A; Department of Radiodiagnosis, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Chatterjee R; Departments of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Marak RSK; Department of Microbiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Aggarwal A; Departments of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India. .
Źródło:: Clinical rheumatology [Clin Rheumatol] 2022 Jan; Vol. 41 (1), pp. 307-312. Date of Electronic Publication: 2021 Oct 04.
Typ publikacji:: Case Reports; Journal Article; Review
Język:: English
Imprint Name(s):: Publication: <2008->: Heidelberg : Springer
Original Publication: Brussels : Acta Medica Belgica, [1982-
MeSH Terms:: Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/drug therapy
Lupus Nephritis*
Mucormycosis*/complications
Mucormycosis*/diagnosis
Mucormycosis*/drug therapy
Adult ; Cyclophosphamide ; Female ; Humans ; Methylprednisolone/therapeutic use ; Young Adult
References:: Prakash H, Chakrabarti A (2019) Global epidemiology of mucormycosis. J Fungi (Basel) 5(1):26. (PMID: 10.3390/jof5010026)
Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DCM et al (2019) The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect 25(1):26–34. (PMID: 10.1016/j.cmi.2018.07.011)
Singh AK, Singh R, Joshi SR, Misra A (2021) Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 15(4):102146. (PMID: 10.1016/j.dsx.2021.05.019)
Lao M, Wang X, Ding M, Yang Z, Chen H, Liang L et al (2019) Invasive fungal disease in patients with systemic lupus erythematosus from Southern China: a retrospective study. Lupus 28(1):77–85. (PMID: 10.1177/0961203318817118)
Jung JY, Yoon D, Choi Y, Kim HA, Suh CH (2019) Associated clinical factors for serious infections in patients with systemic lupus erythematosus. Sci Rep 9(1):9704. (PMID: 10.1038/s41598-019-46039-5)
Burt RK, Traynor A, Statkute L, Barr WG, Rosa R, Schroeder J et al (2006) Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 295(5):527–535. (PMID: 10.1001/jama.295.5.527)
Jindal B, Joshi K, Radotra BD, Banerjee AK (2000) Fatal complications of systemic lupus erythematosus–an autopsy study from north India. Indian J Pathol Microbiol 43(3):311–317. (PMID: 11218678)
Wong KL, Tai YT, Loke SL, Woo EK, Wong WS, Chan MK et al (1986) Disseminated zygomycosis masquerading as cerebral lupus erythematosus. Am J Clin Pathol 86(4):546–549. (PMID: 10.1093/ajcp/86.4.546)
Bloxham CA, Carr S, Ryan DW, Kesteven PJ, Bexton RS, Griffiths ID et al (1990) Disseminated zygomycosis and systemic lupus erythematosus. Intensive Care Med 16(3):201–207. (PMID: 10.1007/BF01724803)
Fingerote RJ, Seigel S, Atkinson MH, Lewkonia RM (1990) Disseminated zygomycosis associated with systemic lupus erythematosus. J Rheumatol 17(12):1692–1694. (PMID: 2084248)
Coffey MJ, Fantone J, Stirling MC, Lynch JP (1992) Pseudoaneurysm of pulmonary artery in mucormycosis. Radiographic characteristics and management. Am Rev Respir Dis 145(6):1487–90. (PMID: 10.1164/ajrccm/145.6.1487)
Liu MF, Chen FF, Hsiue TR, Liu CC (2000) Disseminated zygomycosis simulating cerebrovascular disease and pulmonary alveolar haemorrhage in a patient with systemic lupus erythematosus. Clin Rheumatol 19(4):311–314. (PMID: 10.1007/s100670070052)
Hung HC, Shen GY, Chen SC, Yeo KJ, Tsao SM, Lee MC et al (2015) Pulmonary mucormycosis in a patient with systemic lupus erythematosus: a diagnostic and treatment challenge. Case Rep Infect Dis. 2015:478789. (PMID: 261856934491550)
de Clerck F, Van Ryckeghem F, Depuydt P, Benoit D, Druwé P, Hugel A et al (2014) Dual disseminated infection with Nocardia farcinica and Mucor in a patient with systemic lupus erythematosus: a case report. J Med Case Rep 20(8):376. (PMID: 10.1186/1752-1947-8-376)
Rangwala SD, Strickland BA, Rennert RC, Ravina K, Bakhsheshian J, Hurth K et al (2019) Ruptured mycotic aneurysm of the distal circulation in a patient with mucormycosis without direct skull base extension: case report. Oper Neurosurg (Hagerstown) 16(3):E101–E107. (PMID: 10.1093/ons/opy127)
Martínez-Martínez MU, Herrera-Van Oostdam D, Román-Acosta S, Magaña-Aquino M, Baranda-Cándido L, Abud-Mendoza C (2012) Invasive fungal infections in patients with systemic lupus erythematosus. J Rheumatol 39(9):1814–1818. (PMID: 10.3899/jrheum.111498)
Su CF, Lai CC, LI TH, Chang YF, Lin YT, Tsai CY et al (2020) Risk of invasive fungal infection in systemic lupus erythematosus: a nationwide population based study in Taiwan. Ann Rheum Dis. 79(Suppl 1):876.
Jung J, Kim MY, Lee HJ, Park YS, Lee SO, Choi SH et al (2015) Comparison of computed tomographic findings in pulmonary mucormycosis and invasive pulmonary aspergillosis. Clin Microbiol Infect 21(7):684.e11–8. (PMID: 10.1016/j.cmi.2015.03.019)
Peng M, Meng H, Sun Y, Xiao Y, Zhang H, Lv K et al (2019) Clinical features of pulmonary mucormycosis in patients with different immune status. J Thorac Dis 11(12):5042–5052. (PMID: 10.21037/jtd.2019.12.53)
Reid G, Lynch JP 3rd, Fishbein MC, Clark NM (2020) Mucormycosis. Semin Respir Crit Care Med 41(1):99–114. (PMID: 10.1055/s-0039-3401992)
Agrawal R, Yeldandi A, Savas H, Parekh ND, Lombardi PJ, Hart EM. Pulmonary Mucormycosis: Risk Factors, Radiologic Findings, and Pathologic Correlation. Radiographics. 2020 May-Jun;40(3):656–666.
Hamilos G, Samonis G, Kontoyiannis DP (2011) Pulmonary mucormycosis. Semin Respir Crit Care Med 32(6):693–702. (PMID: 10.1055/s-0031-1295717)
Ruhnke M, Behre G, Buchheidt D, Christopeit M, Hamprecht A, Heinz W et al (2018) Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology (AGIHO). Mycoses 61(11):796–813. (PMID: 10.1111/myc.12838)
Skiada A, Lanternier F, Groll AH, Pagano L, Zimmerli S, Herbrecht R et al (2013) European Conference on Infections in Leukemia. Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3). Haematologica 98(4):492–504. (PMID: 10.3324/haematol.2012.065110)
Spellberg B, Ibrahim AS (2010) Recent advances in the treatment of mucormycosis. Curr Infect Dis Rep 12(6):423–429. (PMID: 10.1007/s11908-010-0129-9)
Stone NR, Bicanic T, Salim R, Hope W (2016) Liposomal amphotericin B (AmBisome(®)): a review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions. Drugs 76(4):485–500. (PMID: 10.1007/s40265-016-0538-7)
Fernandez JF, Maselli DJ, Simpson T, Restrepo MI (2013) Pulmonary mucormycosis: what is the best strategy for therapy? Respir Care 58(5):e60–e63. (PMID: 23107233)
Sipsas NV, Gamaletsou MN, Anastasopoulou A, Kontoyiannis DP (2018) Therapy of mucormycosis. J Fungi (Basel) 4(3):90. (PMID: 10.3390/jof4030090)
Brunet K, Rammaert B. Mucormycosis treatment: recommendations, latest advances, and perspectives. J Mycol Med. 2020 Sep;30(3):101007.
Contributed Indexing:: Keywords: Amphotericin B; Mucormycosis; Systemic lupus erythematosus
Substance Nomenclature:: 8N3DW7272P (Cyclophosphamide)
X4W7ZR7023 (Methylprednisolone)
Entry Date(s):: Date Created: 20211004 Date Completed: 20220105 Latest Revision: 20220727
Update Code:: 20240105
PubMed Central ID:: PMC8488537
DOI:: 10.1007/s10067-021-05941-y
PMID:: 34606036
: Czasopismo naukowe

Full Text Finder

Pulmonary mucormycosis is rare in systemic lupus erythematosus. A 20-year-old lady with lupus nephritis and neuropsychiatric lupus was treated with injection methylprednisolone and cyclophosphamide. After few days, she developed fever, breathlessness, and hoarseness of voice. After neck and chest imaging, possibility of mucormycosis was considered which was later confirmed on microbiological test. Patient was treated with conventional amphotericin B. Literature review was done, and 8 patients with disseminated or pulmonary mucormycosis were identified with SLE. In patients with high index of suspicion, early imaging can help in diagnosis and early and aggressive management even with conventional amphotericin B can result in favorable outcome. Key Points • Pulmonary mucormycosis in systemic lupus erythematosus is rare. • Radiological investigation can guide towards diagnosis. • Early and aggressive treatment can lead to good outcome.
(© 2021. International League of Associations for Rheumatology (ILAR).)

Informacja